BACKGROUND: Hematopoietic stem cell transplantation (HSCT) can be challenging to pediatric recipients and their families. Little is known about the recipients' psychological status as they initiate treatment and in the year afterwards. The purpose of this study is to describe the psychological status of 107 pediatric HSCT recipients from their parents' perspective, and to compare reports from parents and children in a subset of 55 children. We hypothesized that there would be discrepancies between parent and child report of child distress. PROCEDURE: Multi-site, prospective study of eligible child participants and their parents who completed selected modules from the Structured Clinical Interview for DSM-IV-TR, Childhood Version (KID-SCID) the month before and one year after HSCT. Diagnoses were threshold or subthreshold. RESULTS: According to parents, nearly 30% of children had anxiety disorder both before and after HSCT; approximately half of these met threshold criteria. Agreement between parents and children for anxiety disorders was poor at baseline (κ = -0.18, 95%CI = -0.33, -0.02) and fair at 12 months (κ = 0.31, 95%CI = -0.04, 0.66). Agreement about mood disorders was fair at baseline (10% prevalence, κ = 0.39, 95%CI = -0.02, 0.79) and moderate at 12 months (14% prevalence, κ = 0.41, 95%CI = 0.02, 0.80). CONCLUSIONS: Anxiety (30%) and mood (10-14%) symptoms are common in children both before and after HSCT; parent and child reports of these symptoms do not agree. Input from parents and children is recommended to identify more accurately children who may need additional intervention during and following HSCT.
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) can be challenging to pediatric recipients and their families. Little is known about the recipients' psychological status as they initiate treatment and in the year afterwards. The purpose of this study is to describe the psychological status of 107 pediatric HSCT recipients from their parents' perspective, and to compare reports from parents and children in a subset of 55 children. We hypothesized that there would be discrepancies between parent and child report of child distress. PROCEDURE: Multi-site, prospective study of eligible childparticipants and their parents who completed selected modules from the Structured Clinical Interview for DSM-IV-TR, Childhood Version (KID-SCID) the month before and one year after HSCT. Diagnoses were threshold or subthreshold. RESULTS: According to parents, nearly 30% of children had anxiety disorder both before and after HSCT; approximately half of these met threshold criteria. Agreement between parents and children for anxiety disorders was poor at baseline (κ = -0.18, 95%CI = -0.33, -0.02) and fair at 12 months (κ = 0.31, 95%CI = -0.04, 0.66). Agreement about mood disorders was fair at baseline (10% prevalence, κ = 0.39, 95%CI = -0.02, 0.79) and moderate at 12 months (14% prevalence, κ = 0.41, 95%CI = 0.02, 0.80). CONCLUSIONS:Anxiety (30%) and mood (10-14%) symptoms are common in children both before and after HSCT; parent and child reports of these symptoms do not agree. Input from parents and children is recommended to identify more accurately children who may need additional intervention during and following HSCT.
Authors: Laura C Michaelis; Ayman Saad; Xiaobo Zhong; Jennifer Le-Rademacher; Cesar O Freytes; David I Marks; Hillard M Lazarus; Jennifer M Bird; Leona Holmberg; Rammurti T Kamble; Shaji Kumar; Michael Lill; Kenneth R Meehan; Wael Saber; Jeffrey Schriber; Jason Tay; Dan T Vogl; Baldeep Wirk; Bipin N Savani; Robert P Gale; David H Vesole; Gary J Schiller; Muneer Abidi; Kenneth C Anderson; Taiga Nishihori; Matt E Kalaycio; Julie M Vose; Jan S Moreb; William Drobyski; Reinhold Munker; Vivek Roy; Armin Ghobadi; H Kent Holland; Rajneesh Nath; L Bik To; Angelo Maiolino; Adetola A Kassim; Sergio A Giralt; Heather Landau; Harry C Schouten; Richard T Maziarz; Joseph Mikhael; Tamila Kindwall-Keller; Patrick J Stiff; John Gibson; Sagar Lonial; Amrita Krishnan; Angela Dispenzieri; Parameswaran Hari Journal: Biol Blood Marrow Transplant Date: 2013-01-05 Impact factor: 5.742
Authors: Jeffrey M Lyness; Moonseong Heo; Catherine J Datto; Thomas R Ten Have; Ira R Katz; Rebecca Drayer; Charles F Reynolds; George S Alexopoulos; Martha L Bruce Journal: Ann Intern Med Date: 2006-04-04 Impact factor: 25.391
Authors: Lisa Jobe-Shields; Melissa A Alderfer; Maru Barrera; Kathryn Vannatta; Joseph M Currier; Sean Phipps Journal: J Dev Behav Pediatr Date: 2009-04 Impact factor: 2.225
Authors: Melissa A Alderfer; Ifigenia Mougianis; Lamia P Barakat; David Beele; Susan DiTaranto; Wei-Ting Hwang; Anne T Reilly; Anne E Kazak Journal: Cancer Date: 2009-09-15 Impact factor: 6.860
Authors: Christina K Ullrich; Angie Mae Rodday; Kristin M Bingen; Mary Jo Kupst; Sunita K Patel; Karen L Syrjala; Lynnette L Harris; Christopher J Recklitis; Grace Chang; Eva C Guinan; Norma Terrin; Hocine Tighiouart; Sean Phipps; Susan K Parsons Journal: Cancer Date: 2017-04-07 Impact factor: 6.860
Authors: Christina K Ullrich; Angie Mae Rodday; Kristin Bingen; Mary Jo Kupst; Sunita K Patel; Karen L Syrjala; Lynnette L Harris; Christopher J Recklitis; Lisa Schwartz; Stella Davies; Eva C Guinan; Grace Chang; Joanne Wolfe; Susan K Parsons Journal: Biol Blood Marrow Transplant Date: 2015-09-05 Impact factor: 5.742
Authors: Silvia Zanato; Annalisa Traverso; Marta Tremolada; Francesco Sinatora; Alessio Porreca; Giorgio Pozziani; Nicoletta Di Florio; Fabia Capello; Antonio Marzollo; Manuela Tumino; Chiara Cattelan; Giuseppe Basso; Chiara Messina Journal: Front Psychol Date: 2017-04-05